Redekop WK - Search Results

1

The Socioeconomic Benefit to Individuals of Achieving the 2020 Targets for Five Preventive Chemotherapy Neglected Tropical Diseases.

Redekop WK, Lenk EJ, Luyendijk M, Fitzpatrick C, Niessen L, Stolk WA, Tediosi F, Rijnsburger AJ, Bakker R, Hontelez JA, Richardus JH, Jacobson J, de Vlas SJ, Severens JL. Redekop WK, et al. PLoS Negl Trop Dis. 2017 Jan 19;11(1):e0005289. doi: 10.1371/journal.pntd.0005289. eCollection 2017 Jan. PLoS Negl Trop Dis. 2017. PMID: 28103243 Free PMC article.

2

Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes.

Redekop WK, Koopmanschap MA, Stolk RP, Rutten GE, Wolffenbuttel BH, Niessen LW. Redekop WK, et al. Diabetes Care. 2002 Mar;25(3):458-63. doi: 10.2337/diacare.25.3.458. Diabetes Care. 2002. PMID: 11874930

3

Resource consumption and costs in Dutch patients with type 2 diabetes mellitus. Results from 29 general practices.

Redekop WK, Koopmanschap MA, Rutten GE, Wolffenbuttel BH, Stolk RP, Niessen LW. Redekop WK, et al. Diabet Med. 2002 Mar;19(3):246-53. doi: 10.1046/j.1464-5491.2002.00654.x. Diabet Med. 2002. PMID: 11918627

4

Cost-effectiveness of prevention and treatment of the diabetic foot: a Markov analysis.

Ortegon MM, Redekop WK, Niessen LW. Ortegon MM, et al. Among authors: redekop wk. Diabetes Care. 2004 Apr;27(4):901-7. doi: 10.2337/diacare.27.4.901. Diabetes Care. 2004. PMID: 15047646

5

Costs and effects of secondary prevention with perindopril in stable coronary heart disease in Poland: an analysis of the EUROPA study including 1251 Polish patients.

Redekop WK, Orlewska E, Maciejewski P, Rutten FF, Niessen LW. Redekop WK, et al. Pharmacoeconomics. 2008;26(10):861-77. doi: 10.2165/00019053-200826100-00006. Pharmacoeconomics. 2008. PMID: 18793033

6

Relationships among self-management, patient perceptions of care, and health economic outcomes for decision-making and clinical practice in type 2 diabetes.

Cobden DS, Niessen LW, Barr CE, Rutten FF, Redekop WK. Cobden DS, et al. Among authors: redekop wk. Value Health. 2010 Jan-Feb;13(1):138-47. doi: 10.1111/j.1524-4733.2009.00587.x. Epub 2009 Aug 20. Value Health. 2010. PMID: 19695005 Free article. Review.

7

Cost-effectiveness of the diabetes care protocol, a multifaceted computerized decision support diabetes management intervention that reduces cardiovascular risk.

Cleveringa FG, Welsing PM, van den Donk M, Gorter KJ, Niessen LW, Rutten GE, Redekop WK. Cleveringa FG, et al. Among authors: redekop wk. Diabetes Care. 2010 Feb;33(2):258-63. doi: 10.2337/dc09-1232. Epub 2009 Nov 23. Diabetes Care. 2010. PMID: 19933991 Free PMC article. Clinical Trial.

8

Modeling the economic impact of medication adherence in type 2 diabetes: a theoretical approach.

Cobden DS, Niessen LW, Rutten FF, Redekop WK. Cobden DS, et al. Among authors: redekop wk. Patient Prefer Adherence. 2010 Sep 7;4:283-90. doi: 10.2147/ppa.s12121. Patient Prefer Adherence. 2010. PMID: 20859455 Free PMC article.

9

Challenges in modelling the cost effectiveness of various interventions for cardiovascular disease.

Burgers LT, Redekop WK, Severens JL. Burgers LT, et al. Among authors: redekop wk. Pharmacoeconomics. 2014 Jul;32(7):627-37. doi: 10.1007/s40273-014-0155-9. Pharmacoeconomics. 2014. PMID: 24748448 Review.

10

Is it cost-effective to use a test to decide which individuals with an intermediate cardiovascular disease risk would benefit from statin treatment?

Burgers LT, Nauta ST, Deckers JW, Severens JL, Redekop WK. Burgers LT, et al. Among authors: redekop wk. Int J Cardiol. 2014 Oct 20;176(3):980-7. doi: 10.1016/j.ijcard.2014.08.134. Epub 2014 Sep 2. Int J Cardiol. 2014. PMID: 25217221

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

172 results

Search Page

Filters